What's new

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Apr 4, 2025 - 13:57
 0
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Imperial Hotel, Kyoto joins The Leading Hotels of the World (LHW）

Next Article

China to impose 34% retaliatory tariff on all US imports from Apr 10

Related Posts

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues Treatment of familial chylomicronaemia syndrome, 19/07/2021 Positive

Orphan designation: Synthetic double-stranded siRNA oli...

Feb 24, 2025  0

European Shortages Monitoring Platform (ESMP): Implemen...

Mar 10, 2025  0

Human medicines European public assessment report (EPAR): ReFacto AF, moroctocog alfa, Date of authorisation: 13/04/1999, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0